Status:
COMPLETED
Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Quality of Life
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Effectiveness of hilotherapy for the prevention of oxaliplatin-induced peripheral neuropathy and pain in the treatment of gastrointestinal tumors: A randomized controlled trial.
Detailed Description
This study investigates whether constant cooling of the hands and feet using Hilotherm ChemoCare devices reduces the incidence of (severe) oxaliplatin-induced peripheral neuropathy and pain compared t...
Eligibility Criteria
Inclusion
- Most important Eligibility Criteria:
- 18 years or older
- Gastro-intestinal tumor, treated in UZ Leuven (University Hospitals of Leuven)
- Starting oxaliplatin-based treatment
Exclusion
- Already grade 2 or higher peripheral neuropathy
- For a more detailed list, see protocol.
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04913376
Start Date
May 17 2021
End Date
October 25 2022
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Flemish-Brabant, Belgium, 3000